ExeGi Pharma announces first patient enrollment in the PROF Trial of EXE-346
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
There has been no loss or injury to human life
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
GMM Pfaudler US completes acquisition of MixPro
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
Subscribe To Our Newsletter & Stay Updated